Featured post

#Update: Increase in #Human #Infections with #Avian #Influenza #H7N9 Viruses During the 5th #Epidemic — #China, Oct. ‘16–Aug. 7 ‘17 (@CDCgov, edited)

Title : #Update: Increase in #Human #Infections with #Avian #Influenza #H7N9 Viruses During the 5th #Epidemic — #China, Oct. ‘16–Aug. 7 ‘17....

12 Jun 2017

#Influenza and other #Respiratory #Viruses #Research #References #Library– June 12 2017 Issue

Title: #Influenza and other #Respiratory #Viruses #Research #References #Library– June 12 2017 Issue.

Subject: Animal and Human Influenza Viruses, other respiratory pathogens research, weekly reference library update.

Source: AMEDEO, homepage: (LINK).

Code: [  R  ]


New References:


  1. YAMASHITA N, Yashiro M, Ogawa H, Namba H, et al.
    • Metabolic pathway catalyzed by Vanin-1 pantetheinase plays a suppressive role in influenza virus replication in human alveolar epithelial A549 cells.
  2. KING JC, Schweinle JE, Hatchett RJ, Gao Y, et al.
  3. ZHANG X, Xu G, Wang C, Jiang M, et al.
    • Enhanced pathogenicity and neurotropism of mouse-adapted H10N7 influenza virus are mediated by novel PB2 and NA mutations.
  4. NAGUIB MM, Grund C, Arafa AS, Abdelwhab EM, et al.
    • Heterologous post-infection immunity against Egyptian avian influenza virus (AIV) H9N2 modulates the course of subsequent infection by highly pathogenic AIV H5N1, but vaccination immunity does not.
  5. VIJAYAN M, Xia C, Song YE, Ngo H, et al.
    • Sphingosine 1-Phosphate Lyase Enhances the Activation of IKKepsilon To Promote Type I IFN-Mediated Innate Immune Responses to Influenza A Virus Infection.
  6. KHIEU TQT, Pierse N, Telfar-Barnard LF, Zhang J, et al.
    • Modelled seasonal influenza mortality shows marked differences in risk by age, sex, ethnicity and socioeconomic position in New Zealand.
  7. HEIKKINEN T, Ojala E, Waris M.
  8. LANGLEY JM, Aggarwal N, Toma A, Halperin SA, et al.
    • A randomized, controlled, observer-blind Phase I study of the safety and immunogenicity of a Respiratory Syncytial Virus vaccine with or without alum adjuvant.
  9. UYEKI TM, Katz JM, Jernigan DB.
  10. KURUPATI RK, Kossenkoff A, Kannan S, Haut LH, et al.
    • The effect of timing of influenza vaccination and sample collection on antibody titers and responses in the aged.
  11. SHIM SM, Song EJ, Song D, Lee TY, et al.
    • Nontoxic outer membrane vesicles efficiently increase the efficacy of an influenza vaccine in mice and ferrets.
  12. MANITO ACB, Graf T, Lunge VR, Ikuta N, et al.
    • Spatiotemporal dynamics of influenza A(H1N1)pdm09 in Brazil during the pandemic and post-pandemic periods.
  13. NINPAN K, Suptawiwat O, Boonarkart C, Songprakhon P, et al.
    • Mutations in Matrix Protein 1 and Nucleoprotein caused Human-Specific Defects in Nuclear Exportation and Viral Assembly of an Avian Influenza H7N1 Virus.


Keywords: Research; Abstracts; Influenza References Library.